| Authors: |
Hinner MJ; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany. olwill@pieris.com marlon.jakob@hinner.de., Aiba RSB; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Jaquin TJ; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Berger S; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Dürr MC; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Schlosser C; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Allersdorfer A; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Wiedenmann A; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Matschiner G; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Schüler J; In Vivo Operations, Oncotest GmbH, Freiburg, Germany., Moebius U; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Rothe C; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Matis L; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany., Olwill SA; Research and Development, Pieris Pharmaceuticals GmbH, Freising, Germany. olwill@pieris.com marlon.jakob@hinner.de. |